Lerong Li
- Oncology top 5%
- Molecular Biology top 10%
- Immunology top 10%
- Epidemiology
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Jing WangJohn V. HeymachLauren A. ByersTriparna SenLixia DiaoBonnie S. GlissonDon L. GibbonsYou-Hong Fan
- Topics
- Lung Cancer Research Studies (6 papers)Lung Cancer Treatments and Mutations (5 papers)Cancer Genomics and Diagnostics (4 papers)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Lerong Li
20 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Oncology 827
- Molecular Biology 699
- Immunology 386
- Epidemiology 232
- Pulmonary and Respiratory Medicine 215
Countries citing papers authored by Lerong Li
This map shows the geographic impact of Lerong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lerong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lerong Li more than expected).
Fields of papers citing papers by Lerong Li
This network shows the impact of papers produced by Lerong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lerong Li. The network helps show where Lerong Li may publish in the future.
Co-authorship network of co-authors of Lerong Li
This figure shows the co-authorship network connecting the top 25 collaborators of Lerong Li. A scholar is included among the top collaborators of Lerong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lerong Li. Lerong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemiabreakdown → | 55 |
| 3 | 2 | |
| 4 | 26 | |
| 5 | 58 | |
| 6 | Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancerbreakdown → | 616 |
| 7 | 11 | |
| 8 | 42 | |
| 9 | 12 | |
| 10 | 3 | |
| 11 | 33 | |
| 12 | 101 | |
| 13 | 23 | |
| 14 | 11 | |
| 15 | 145 | |
| 16 | 43 | |
| 17 | 61 | |
| 18 | 67 | |
| 19 | 18 | |
| 20 | 40 |
About Lerong Li
Lerong Li is a scholar working on Oncology, Cancer Research and Cell Biology, having authored 21 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Oncology (827 citations), Immunology (386 citations) and Cancer Research (175 citations). Lerong Li has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Jing Wang, John V. Heymach, Lauren A. Byers, Triparna Sen, Lixia Diao, Bonnie S. Glisson, Don L. Gibbons, You-Hong Fan, Julien Sage and Sandra Cristea. Their work appears in journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.